Literature DB >> 16775576

Update: influenza activity--United States and worldwide, 2005-06 season, and composition of the 2006-07 influenza vaccine.

.   

Abstract

During the 2005-06 influenza season, influenza A (H1N1), A (H3N2), and B viruses cocirculated worldwide. In the United States, influenza A (H3N2) viruses predominated overall, but influenza B viruses were isolated more frequently than influenza A viruses late in the season. Influenza activity in the United States peaked in early March, and the number of pneumonia and influenza deaths did not exceed the epidemic threshold. Worldwide, influenza B viruses were the most commonly reported influenza type in Europe; influenza A (H1N1) and influenza B viruses predominated in Asia. Through June 13, 2006, outbreaks of influenza A (H5N1) viruses (avian influenza) among migratory birds and poultry flocks were associated with severe human illness or death in 10 countries (Azerbaijan, Cambodia, China, Djibouti, Egypt, Indonesia, Iraq, Thailand, Turkey, and Vietnam). This report summarizes influenza activity in the United States and worldwide during the 2005-06 influenza season and describes composition of the 2006-07 influenza vaccine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775576

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  9 in total

1.  Inactivation of influenza A virus on copper versus stainless steel surfaces.

Authors:  J O Noyce; H Michels; C W Keevil
Journal:  Appl Environ Microbiol       Date:  2007-01-26       Impact factor: 4.792

2.  Controlling Time-Dependent Confounding by Health Status and Frailty: Restriction Versus Statistical Adjustment.

Authors:  Leah J McGrath; Alan R Ellis; M Alan Brookhart
Journal:  Am J Epidemiol       Date:  2015-04-12       Impact factor: 4.897

Review 3.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

4.  Predicting Zoonotic Risk of Influenza A Viruses from Host Tropism Protein Signature Using Random Forest.

Authors:  Christine L P Eng; Joo Chuan Tong; Tin Wee Tan
Journal:  Int J Mol Sci       Date:  2017-05-25       Impact factor: 5.923

5.  Oseltamivir prescribing in pharmacy-benefits database, United States, 2004-2005.

Authors:  Justin R Ortiz; Laurie Kamimoto; Ronald E Aubert; Jianying Yao; David K Shay; Joseph S Bresee; Robert S Epstein
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

6.  Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challenge.

Authors:  Andrew S Herbert; Lynn Heffron; Roy Sundick; Paul C Roberts
Journal:  Virol J       Date:  2009-04-24       Impact factor: 4.099

7.  Molecular epidemiology of influenza A/H3N2 viruses circulating in Mexico from 2003 to 2012.

Authors:  Marina Escalera-Zamudio; Martha I Nelson; Ana Georgina Cobián Güemes; Irma López-Martínez; Natividad Cruz-Ortiz; Miguel Iguala-Vidales; Elvia Rodríguez García; Gisela Barrera-Badillo; Jose Alberto Díaz-Quiñonez; Susana López; Carlos F Arias; Pavel Isa
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

8.  Influenza-associated hospitalization in urban Thai children.

Authors:  Piyarat Suntarattiwong; Chotip Sian-nork; Parada Thongtipa; Pranee Thawatsupha; Rungreung Kitphati; Tawee Chotpitayasunondh
Journal:  Influenza Other Respir Viruses       Date:  2007 Sep-Nov       Impact factor: 4.380

Review 9.  The prospect of pandemic influenza: why should the optometrist be concerned about a public health problem?

Authors:  Gregory G Hom; A Paul Chous
Journal:  Optometry       Date:  2007-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.